|Institutional Source||Beutler Lab|
|Gene Name||Eph receptor B3|
|Synonyms||Tyro6, HEK2, MDK5, Sek4, Etk2, Cek10|
|Is this an essential gene?||Probably essential (E-score: 0.904)|
|Stock #||R7452 (G1)|
|Chromosomal Location||21204755-21223305 bp(+) (GRCm38)|
|Type of Mutation||splice site (6 bp from exon)|
|DNA Base Change (assembly)||T to C at 21217357 bp (GRCm38)|
|Amino Acid Change|
|Ref Sequence||ENSEMBL: ENSMUSP00000124375 (fasta)|
|Gene Model||predicted gene model for transcript(s): [ENSMUST00000006112] [ENSMUST00000161063] [ENSMUST00000231316] [ENSMUST00000232407]|
|Meta Mutation Damage Score||0.9755|
|Coding Region Coverage||
|Validation Efficiency||100% (75/75)|
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] Ephrin receptors and their ligands, the ephrins, mediate numerous developmental processes, particularly in the nervous system. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. The Eph family of receptors are divided into two groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. Ephrin receptors make up the largest subgroup of the receptor tyrosine kinase (RTK) family. This gene encodes a receptor for ephrin-B family members. [provided by RefSeq, Mar 2010]
PHENOTYPE: Homozygotes for a targeted null mutation exhibit defects in corpus callosum formation and impaired Paneth cell downward migration in the intestinal epithelium, resulting in scattered positioning along crypt and villus. [provided by MGI curators]
|Allele List at MGI|
|Other mutations in this stock||
|Other mutations in Ephb3||
(F):5'- AAAGGGCCAGGTTCTCTCAG -3'
(R):5'- CTAGCAGCTAGAGAGAACTTGG -3'
(F):5'- AGGGAGATAAATATGTGACATCCTC -3'
(R):5'- CTTGGTAGAATGCAGGCAGATG -3'